Clinical Trials
11
Active:1
Completed:8
Trial Phases
3 Phases
Phase 3:1
Phase 4:3
Not Applicable:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
6 (60.0%)Phase 4
3 (30.0%)Phase 3
1 (10.0%)CAPTURE Study (Polyglucosamine for Cardio & Atherosclerosis Prevention and Treatment Via Fat Uptake REduction)
Not Applicable
Not yet recruiting
- Conditions
- Atherosclerotic Disease
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Certmedica International GmbH
- Target Recruit Count
- 240
- Registration Number
- NCT06910111
- Locations
- 🇮🇹
Pisa University Hospital - Clinical Research Unit, Pisa, Tuscany, Italy
🇮🇹University Gabriele d'Annunzio Chieti - Pescara, Chieti, Italy
🇮🇹S. Maria della Misericordia Hospital, Perugia, Italy
Influence of Polyglucosamine L112 on Serum Surrogate Markers of Cholesterol Absorption
Not Applicable
Completed
- Conditions
- Cholesterol Lowering
- First Posted Date
- 2021-09-09
- Last Posted Date
- 2022-11-18
- Lead Sponsor
- Certmedica International GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT05038436
- Locations
- 🇩🇪
Phase I-Unit, Study Center Bonn (SZB), University Hospital Bonn, Bonn, North-Rhine Westfalia, Germany
Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects
Phase 4
Completed
- Conditions
- Weight Loss
- Interventions
- Drug: Polyglucosamine L112Other: Placebo
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2022-11-22
- Lead Sponsor
- Certmedica International GmbH
- Target Recruit Count
- 150
- Registration Number
- NCT04375696
- Locations
- 🇮🇹
Azienda di Servizi alla Persona Istituzioni Assistenziali Riunite di Pavia, Pavia, Lombardia, Italy
The Artificial Saliva Spray Reduces Xerostomia in Diabetes Type II
Not Applicable
Completed
- Conditions
- Xerostomia Due to Hyposecretion of Salivary GlandDiabetes Mellitus, Type 2
- First Posted Date
- 2018-03-02
- Last Posted Date
- 2018-03-02
- Lead Sponsor
- Certmedica International GmbH
- Target Recruit Count
- 21
- Registration Number
- NCT03452085
- Locations
- 🇮🇹
Irwin Labs, University of Chieti, Chieti, PE, Italy
Efficacy of Polyglucosamine Long Term Treatment
Not Applicable
Completed
- Conditions
- Obesity
- First Posted Date
- 2016-02-15
- Last Posted Date
- 2017-07-25
- Lead Sponsor
- Certmedica International GmbH
- Target Recruit Count
- 100
- Registration Number
- NCT02682277
- Locations
- 🇮🇹
MAP Center, Rende, Cosenza, Italy
- Prev
- 1
- 2
- Next
News
No news found